Osaka, Japan

Yutaro Kotobuki

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Osaka University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaro Kotobuki. Retrieved from https://idiyas.com/inventor/yutaro-kotobuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yutaro Kotobuki: Innovator in Nucleoside Research

Introduction

Yutaro Kotobuki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of oligonucleotides and artificial nucleosides.

Latest Patents

Kotobuki holds a patent for an oligonucleotide and artificial nucleoside featuring a guanidine bridge. This invention is represented by specific chemical formulas and includes various salts of the compound.

Career Highlights

He is affiliated with Osaka University, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential applications in genetic research and therapeutic development.

Collaborations

Kotobuki has collaborated with esteemed colleagues, including Satoshi Obika and Reiko Waki, to advance research in nucleoside chemistry.

Conclusion

Yutaro Kotobuki's contributions to the field of biochemistry through his patent and research at Osaka University highlight his role as an influential inventor in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…